Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 10MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225790 |
APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-06-06 | 225793 |
APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-04-19 | 2024-05-24 | 225796 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-04-19 | 2024-06-07 | 225799 |
APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2024-04-19 | 2024-05-22 | 225802 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Resolved | 2024-04-26 | 2024-06-14 | 226309 |
APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226312 |
APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2024-04-26 | 2024-05-31 | 226315 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2024-04-26 | 2024-04-26 | 226318 |
APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226321 |
APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226324 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226327 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226330 |
APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2024-04-26 | 2024-05-24 | 226333 |
APO-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226336 |
APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-03 | 226339 |
APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226342 |
APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2024-04-26 | 2024-06-14 | 226345 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-26 | 2024-04-26 | 226348 |
APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2024-05-03 | 2024-06-14 | 227016 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |